After several cycles of chemotherapy, the first visible changes often appear at the fingertips and toes. Hand-foot syndrome (palmar-plantar erythrodysesthesia) — redness, burning, dryness and cracking of the palms and soles — is a commonly reported reaction with oral agents such as capecitabine and with some intravenous drugs. Skin is not the only tissue affected. The nail matrix, which manufactures the nail plate, is also a rapidly dividing tissue, so drugs that target fast-growing cells can disturb it as well.
The most familiar result is onycholysis, where the nail separates from its bed. You may also see horizontal grooves (Beau's lines), yellow or dark discoloration, or painful swelling of the skin around the nail (paronychia). An important detail is the time lag: fingernails grow roughly 3 mm per month and toenails about 1 mm. The damage visible today may therefore record a cycle from weeks or months ago, and conversely, nails may look unchanged for some time even after the treatment plan is adjusted.
This also explains why people who walk regularly often notice toenail problems most. Exercise is not really the cause; rather, repeated friction and pressure inside a shoe widen the separation in a nail that has already been weakened. The practical response is not to stop walking but to change the load on the foot: shoes with a roomy toe box, about half a size extra, seamless cotton socks, fewer downhill stretches and sudden stops that jam the toes forward, and several short walks instead of one long one. Seated leg raises, marching in place, or light strength work indoors can keep total activity up on difficult days.
Sometimes a lifted nail is painful or catches on everything and a clinician removes it. This is not an unusual procedure, and some people report relief once the nail no longer rubs. During chemotherapy, however, wound healing and infection risk must be weighed together. Whether to prescribe an antibiotic or to manage the site with cleansing and dressings depends on the wound, blood counts (especially the neutrophil count), current medications, and conditions such as diabetes — so follow the treating team's judgment. Tell your oncology team that the nail was removed; it may matter when the next cycle's timing or dose is decided.
At home, a few habits help: trim nails short and straight across so they do not dig in; avoid long hot soaks, saunas and prolonged foot baths; dry carefully between the toes after washing and then moisturize; skip artificial nails, salon procedures and callus shaving during treatment; and inspect both feet once a day in good light, since reduced sensation can mask a problem that pain alone would reveal.
Agree in advance on what warrants a call. Fever of 38°C or higher or chills, pus or odor from the wound, redness spreading beyond the toe, throbbing pain that keeps worsening, or sudden swelling or darkening of the foot should be reported without waiting for the next scheduled visit. In the window after an infusion when white blood cells drop, even a small wound can escalate quickly.
Finally, hand-foot syndrome and nail toxicity are graded by severity, and that grade may lead to a longer break between cycles or a dose reduction. That is a routine adjustment made so treatment can continue, not an abandonment of it. Skipping or reducing doses on your own is risky; keeping a short note of when symptoms started and how bad they are is far more useful at the next appointment.
This article is general information and does not replace individual diagnosis or medical care. Causes and management differ from person to person, so please discuss your situation with your own healthcare team.